CPT® Code 0506T

Macular pigment optical density measurement by heterochromatic flicker photometry, unilateral or bilateral, with interpretation and report

Macular pigment optical density (MPOD) measurement by heterochromatic flicker photometry is a non-invasive diagnostic procedure that evaluates the density of a specific yellow pigment located in the fovea of the macula, which is the central part of the retina. This pigment, composed of carotenoids such as lutein, meso-zeaxanthin, and zeaxanthin, plays a crucial role in protecting the eye from harmful blue light, which can cause damage to photoreceptors. The measurement of MPOD is significant because low levels of macular pigment are associated with an increased risk of age-related macular degeneration (AMD), a leading cause of vision loss in older adults. The procedure assesses the thickness of this pigment, which can vary among individuals due to factors such as age, genetic predisposition, dietary habits, and lifestyle choices. Symptoms that may indicate thinning of the macular pigment include decreased visual acuity, reduced contrast sensitivity, prolonged glare recovery, and photophobia. During the test, each eye is evaluated separately while the patient focuses on a target. A specialized optical camera introduces a monochromatic blue light with varying wavelengths and intensities, and the responses are recorded and analyzed using computer software. The resulting MPOD measurements are expressed on a scale from 0 to 1, with lower scores indicating a higher risk for developing AMD. This procedure is essential for comprehensive patient risk assessment and the formulation of appropriate treatment plans.